Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Buy
3,785
+180
+5% +$17.3K ﹤0.01% 1524
2026
Q1
$374K Buy
3,605
+715
+25% +$81.1K ﹤0.01% 1392
2025
Q4
$291K Sell
2,890
-1,997
-41% -$217K ﹤0.01% 1386
2025
Q3
$603K Sell
4,887
-11,577
-70% -$1.44M 0.01% 1094
2025
Q2
$1.98M Buy
16,464
+12,841
+354% +$1.71M 0.02% 504
2025
Q1
$533K Buy
3,623
+813
+29% +$124K 0.01% 1002
2024
Q4
$456K Buy
+2,810
New +$460K 0.01% 1000

Other funds holding CLX

Vident Advisory's CLX Position: Q2 2026 in Review

Vident Advisory increased its Clorox (CLX) stake by 5% in Q2 2026, buying an estimated $17.3K and bringing the position to 3,785 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Vident Advisory first reported a position in CLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.98M in Q2 2025. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Vident Advisory held 3,785 shares of Clorox worth $361K as of Q2 2026.
  • Vident Advisory bought 180 Clorox shares in Q2 2026, an estimated $17.3K.
  • Clorox made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1524 holding.
  • Vident Advisory first reported a position in Clorox in Q4 2024 and has held it in 7 quarters since.
  • Vident Advisory's Clorox position peaked at $1.98M in Q2 2025.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.